GO:0050807 regulation of synapse organization: Biological Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050807 regulation of synapse organization describes any process that modulates the physical form of a synapse, the junction between a neuron and a target cell.
• Synapse organization is controlled by cell-adhesion molecules, secreted organizers, and intracellular scaffolds that together determine synapse number, size, and stability.
• Post-translational modifications such as SUMOylation provide rapid, reversible control of synaptic protein interactions and synapse structure.
• Glia and immune signaling are active participants in synapse regulation, forming a tetrapartite synapse that includes pre- and postsynaptic neurons, astrocytes, and microglia.
• Disrupted synapse organization is linked to neurodevelopmental and psychiatric conditions, including anxiety disorders and critical-period plasticity defects.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of synapse-organizing genes in vitro and in vivo.
Description
Regulation of synapse organization (GO:0050807) is a biological process that encompasses any mechanism modulating the physical form of a synapse, the specialized junction between a neuron and a target cell. Synapses are not static structures; their number, size, and molecular composition are continuously adjusted during development and in response to activity, and this structural plasticity is essential for circuit formation and information processing. The term covers diverse regulatory inputs, from secreted synapse organizers and cell-adhesion molecules to intracellular signaling and post-translational modifications. Understanding GO:0050807 is therefore central to neurobiology, because the physical organization of synapses sets the stage for synaptic transmission, plasticity, and behavior. Researchers study this process to identify the molecular rules that build and remodel neural circuits, and to understand how these rules go awry in disease. Because synapse organization is regulated by both neuronal and non-neuronal cells, including glia and immune cells, it sits at the intersection of cell biology, neuroscience, and immunology. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0050807, its key genes, experimental models, and methods.
regulation of synapse organization At A Glance
| GO ID | GO:0050807 |
|---|---|
| GO term | regulation of synapse organization |
| Ontology | biological_process |
| Synonym | regulation of synapse organisation; regulation of synapse organization and biogenesis; regulation of synapse structure |
| Major function | Modulates the physical form, number, and stability of synapses between neurons and their targets |
| Cellular context | Pre- and postsynaptic compartments, glia, and extracellular matrix |
| Key molecular players | Cell-adhesion molecules, secreted synapse organizers, scaffolding proteins, and post-translational modifiers |
| Related processes | Synaptogenesis, synaptic plasticity, critical-period plasticity, and neuroimmune signaling |
What Is GO:0050807?
According to the Gene Ontology, GO:0050807 regulation of synapse organization is defined as any process that modulates the physical form of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell). In other words, it includes all molecular and cellular events that change the structure, number, or stability of synapses, without being restricted to a single mechanism or cell type.
Why Is regulation of synapse organization Important in Cell Biology?
GO:0050807 is important because the physical organization of synapses determines how neural circuits form, mature, and adapt. Structural changes at synapses underlie learning, memory, and sensory critical periods, and their dysregulation is associated with neurodevelopmental and psychiatric disorders. Moreover, synapse organization is not solely a neuronal property; glia and immune cells actively regulate synaptic structure, expanding the therapeutic targets for brain disorders.
• Defines the structural basis of synaptic transmission and plasticity.
• Controls synapse number and size during development and in adulthood.
• Regulates critical-period plasticity in sensory and associative circuits.
• Is modulated by post-translational modifications such as SUMOylation.
• Involves glial and immune cells in a tetrapartite synapse model.
• Dysregulation is linked to anxiety circuitry and emotional disorders.
• Provides targets for neurodevelopmental and neurodegenerative disease research.
• Enables mechanistic studies using Drosophila and mammalian genetic models.
• Informs CRISPR-based screens for synapse-regulating genes.
• Bridges cell biology, neuroscience, and immunology.
What Happens During regulation of synapse organization?
Initiation by cell-adhesion and secreted organizers
In simple terms: Special proteins on the outside of neurons tell the pre- and postsynaptic sides where to connect and how big the connection should be.
Synapse organization begins with trans-synaptic adhesion complexes and secreted molecules that physically bridge the presynaptic and postsynaptic membranes. In Drosophila, genetic studies have identified multiple cell-adhesion and secreted proteins that control central synapse formation and organization. In mammals, synapse organizers such as neuroligins and neurexins, together with extracellular scaffolds, initiate and stabilize synaptic contacts. These initial interactions determine the location and initial size of the synapse, and they recruit intracellular scaffolds that will further shape its structure.
Intracellular scaffolding and cytoskeletal remodeling
In simple terms: Inside the neuron, scaffold proteins and the cytoskeleton build a framework that holds the synapse together and allows it to change shape.
Once adhesion molecules have specified a synaptic site, intracellular scaffolding proteins assemble a dense network that anchors receptors and organizes the active zone and postsynaptic density. This process involves regulated cytoskeletal dynamics that control spine morphology and bouton size. Genetic pathways such as the Bcl11b/C1ql2/Nrxn3(25b+) pathway regulate the function and structure of hippocampal mossy fiber-CA3 synapses, demonstrating that specific transcriptional and adhesion programs control synapse organization in defined circuits.
Post-translational modification and dynamic regulation
In simple terms: Chemical tags added to synaptic proteins can quickly change how they interact, allowing synapses to remodel without making new proteins.
Post-translational modifications provide rapid and reversible control of synapse organization. SUMOylation, the covalent attachment of SUMO peptides to target proteins, regulates the molecular organization of mammalian synapses by altering protein interactions and stability. This modification can change the clustering of synaptic proteins and influence synapse structure in response to activity, illustrating how GO:0050807 integrates signaling with structural change.
Glial and neuroimmune contributions
In simple terms: Support cells in the brain, including astrocytes and microglia, also help shape synapses by releasing signals and pruning connections.
Synapse organization is not exclusively neuronal. Glia participate in synapse nano-organization, influencing the precise arrangement of proteins at the synapse. In the prefrontal cortex, neuroimmune signaling contributes to a tetrapartite synapse model that includes pre- and postsynaptic neurons, astrocytes, and microglia, where immune molecules modulate synaptic structure and function. These findings expand GO:0050807 to include non-neuronal regulatory inputs that are critical for circuit refinement and disease.
Activity-dependent refinement and critical periods
In simple terms: Experience and neural activity can strengthen or weaken synapses, and during certain developmental windows these changes are especially powerful.
Synapse organization is refined by activity during critical periods of development. Synapse organizers regulate the timing and closure of critical periods, thereby controlling when circuits are most malleable. In the amygdala, inhibitory circuits that regulate anxiety are shaped by synapse organization, and disruption of this process can alter emotional behavior. Thus, GO:0050807 encompasses both the initial assembly and the experience-dependent remodeling of synapses.
Key Genes Involved in GO:0050807 regulation of synapse organization
The following genes and proteins are representative regulators of synapse organization, based on the verified literature cited in this article.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Nlgn1 (Neuroligin-1) | Postsynaptic adhesion molecule that organizes excitatory synapses | Model for synapse organizer function and critical periods |
| Nrxn1 (Neurexin-1) | Presynaptic adhesion molecule that binds neuroligins | Studied in synapse formation and neurodevelopmental disorders |
| C1ql2 | Secreted synapse organizer in hippocampal mossy fiber-CA3 circuit | Regulates synapse function via Bcl11b pathway |
| Bcl11b | Transcription factor controlling circuit-specific synapse organization | Required for mossy fiber-CA3 synapse function |
| Nrxn3(25b+) | Presynaptic neurexin isoform | Part of Bcl11b/C1ql2/Nrxn3 pathway |
| Sumo1/2/3 | SUMOylation modifiers of synaptic proteins | Regulate synapse molecular organization |
| Ubc9 | SUMO-conjugating enzyme | Catalyzes SUMOylation of synaptic targets |
| Gephyrin | Postsynaptic scaffold at inhibitory synapses | Target of SUMOylation and regulator of synapse structure |
| PSD-95 | Postsynaptic scaffold at excitatory synapses | Organizes receptor clustering and spine morphology |
| SAP102 | Postsynaptic scaffold | Contributes to excitatory synapse organization |
| C1q | Complement protein involved in synapse pruning | Neuroimmune regulation of synapses |
| CX3CR1 | Microglial receptor | Modulates microglia-neuron interactions at synapses |
| Gfap | Astrocyte marker and regulator | Glial contribution to synapse nano-organization |
| Arc | Activity-regulated cytoskeletal protein | Links activity to synapse structural plasticity |
| Homer1 | Postsynaptic scaffold | Regulates metabotropic glutamate receptor signaling and synapse structure |
| Shank3 | Postsynaptic scaffold | Synapse organization and neurodevelopmental disorders |
| Dlg1 (SAP97) | Membrane-associated guanylate kinase | Presynaptic and postsynaptic organization |
How Is regulation of synapse organization Regulated?
Regulation of synapse organization is itself regulated at multiple levels. Transcriptional programs, such as the Bcl11b pathway, control the expression of synapse-organizing molecules in a circuit-specific manner. Post-translational modifications, particularly SUMOylation, dynamically alter protein interactions and stability at the synapse. Activity-dependent signaling and critical-period regulators set the timing of structural plasticity. In addition, neuroimmune and glial signals, including complement proteins and microglial receptors, actively modulate synapse structure and pruning.
regulation of synapse organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLGN1 | Autism spectrum disorder, critical-period plasticity | Knockout mouse, point-mutation knock-in |
| NRXN1 | Schizophrenia, neurodevelopmental delay | Conditional knockout, overexpression |
| BCL11B | Circuit-specific synapse dysfunction | Knockout and rescue in mouse hippocampus |
| C1QL2 | Hippocampal synapse function | Knockout mouse, tagged knock-in |
| SUMO1 | Synaptic protein aggregation, neurodegeneration | SUMOylation-deficient knock-in |
Neurodevelopmental and psychiatric disorders
Disruption of synapse organization is increasingly recognized in neurodevelopmental and psychiatric conditions. Mutations in synapse organizers such as neuroligins and neurexins have been associated with autism spectrum disorders and schizophrenia, and critical-period dysregulation may contribute to these phenotypes. In the amygdala, altered inhibitory synapse organization can affect anxiety circuitry, linking GO:0050807 to emotional disorders.
Neurodegeneration and synapse loss
Synapse loss is a hallmark of neurodegenerative diseases, and mechanisms that regulate synapse organization may be protective or pathogenic. SUMOylation of synaptic proteins can influence synapse stability, and its dysregulation has been implicated in protein aggregation and synaptic dysfunction. Glial and neuroimmune pathways that normally organize synapses can become overactive and drive pathological pruning in disease.
Critical-period disorders
Because synapse organizers regulate critical periods, their dysfunction can lead to disorders of sensory and cognitive development. Emerging roles of synapse organizers in critical-period regulation suggest that abnormal timing of structural plasticity may underlie conditions such as amblyopia and certain forms of intellectual disability.
From regulation of synapse organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce synapse number? | CRISPR knockout in primary neurons or cell lines |
| Does a disease-associated point mutation alter synapse organization? | Point-mutation knock-in via CRISPR |
| Where and when is a synapse organizer expressed? | Tagged knock-in with fluorescent reporter |
| Can overexpression rescue a synapse phenotype? | CRISPR-mediated overexpression or cDNA delivery |
| Which genes regulate synapse structure in a circuit? | In vivo CRISPR library screening in mouse brain |
| How does SUMOylation affect synaptic protein interactions? | Knock-in of SUMOylation-deficient alleles |
How to Study the regulation of synapse organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on synapse number | Screen candidate synapse organizers |
| Point-mutation knock-in | Effect of disease variants on synapse structure | Model neurodevelopmental disorders |
| Tagged knock-in | Protein localization and dynamics | Visualize synapse organizers in vivo |
| Super-resolution microscopy | Nanoscale organization of synaptic proteins | Study glia-synapse interactions |
| Proteomics | Synaptic protein composition and modifications | Identify SUMOylated targets |
| Electrophysiology | Synaptic transmission and plasticity | Assess functional impact of structural changes |
| Immunohistochemistry | Synapse density and morphology | Quantify structural plasticity |
| RNA-seq | Transcriptional programs controlling synapse organization | Identify regulators in disease models |
Genetic perturbation and CRISPR screens
CRISPR-based knockout, point mutation, knock-in, and overexpression enable causal testing of synapse-organizing genes. In Drosophila, genetic screens have identified regulators of central synapse formation and organization. In mammals, CRISPR screens can be applied to primary neurons or in vivo to discover new regulators of synapse structure.
Imaging and synapse quantification
Confocal and super-resolution microscopy allow quantification of synapse number, size, and molecular composition. Glia-synapse nano-organization can be visualized using super-resolution techniques. Co-localization of pre- and postsynaptic markers is a standard readout for synapse organization.
Biochemical and proteomic analysis
Proteomics and co-immunoprecipitation can identify synaptic protein complexes and their post-translational modifications. SUMOylation of synaptic proteins can be detected by immunoblotting and mass spectrometry. Understanding the molecular diversity of synapses benefits from advanced proteomic approaches.
Electrophysiology and functional assays
Electrophysiological recordings measure synaptic transmission and plasticity, providing functional correlates of structural changes. Hippocampal mossy fiber-CA3 synapse function can be assessed by field recordings in mice with genetic manipulations. These assays link GO:0050807 to circuit output.
How CRISPR Can Be Used to Study GO:0050807 regulation of synapse organization
Knockout
CRISPR knockout is used to delete candidate synapse-organizing genes and assess loss-of-function effects on synapse number, size, and function. For example, knockout of Bcl11b or C1ql2 in mice disrupts hippocampal mossy fiber-CA3 synapse function. Knockout of neuroligins or neurexins can reveal their roles in synapse organization and critical periods.
Point Mutation
Point-mutation knock-in via CRISPR allows modeling of disease-associated variants in synapse organizer genes. This approach can test whether a specific amino acid change alters synaptic adhesion or scaffolding, as has been explored for neurodevelopmental disorder variants. Such models are essential for linking genetic variants to structural synapse phenotypes.
Knock-in
Knock-in of tags or reporters enables visualization and biochemical isolation of synapse-organizing proteins. Tagged knock-in of C1ql2 or Nrxn3 allows tracking of their localization and interactions in vivo. Knock-in of SUMOylation-deficient alleles can test the role of post-translational modifications in synapse organization.
Overexpression
CRISPR-mediated overexpression or cDNA delivery can test sufficiency of a candidate gene to drive synapse formation or rescue phenotypes. Overexpression of synapse organizers may enhance synapse number or function, providing insights into critical-period regulation. This approach complements loss-of-function studies to establish causality.
How EDITGENE Supports regulation of synapse organization Research
Researchers studying regulation of synapse organization-related genes often need to determine whether a candidate gene is causally involved in synapse structure and function. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models, enabling rigorous testing of hypotheses about GO:0050807.
Contact EDITGENE today to design your custom CRISPR model for regulation of synapse organization research.
Frequently Asked Questions About regulation of synapse organization
What is GO:0050807 regulation of synapse organization?
GO:0050807 is a Gene Ontology biological process term defined as any process that modulates the physical form of a synapse, the junction between a neuron and a target cell.
What genes are involved in regulation of synapse organization?
Key genes include NLGN1, NRXN1, C1QL2, BCL11B, NRXN3, SUMO1, and scaffolding genes such as PSD-95 and Gephyrin.
How is synapse organization regulated?
It is regulated by cell-adhesion molecules, secreted organizers, intracellular scaffolds, post-translational modifications like SUMOylation, and glial/neuroimmune signals.
Why is regulation of synapse organization important?
It controls circuit formation, plasticity, and critical periods, and its disruption is linked to neurodevelopmental and psychiatric disorders.
What diseases are associated with defective synapse organization?
Neurodevelopmental disorders, schizophrenia, anxiety disorders, and neurodegeneration have been associated with altered synapse organization.
How can I study regulation of synapse organization in the lab?
CRISPR knockout, point-mutation knock-in, tagged knock-in, overexpression, imaging, electrophysiology, and proteomics are common approaches.
What is the role of SUMOylation in synapse organization?
SUMOylation modifies synaptic proteins and regulates their interactions, thereby controlling synapse molecular organization.
Do glia regulate synapse organization?
Yes, glia and microglia participate in synapse nano-organization and pruning, forming a tetrapartite synapse.
Which model organisms are used to study synapse organization?
Drosophila melanogaster and mice are widely used, with genetic screens and circuit-specific manipulations.
How does EDITGENE support synapse organization research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for synapse-related genes.
Conclusion
GO:0050807 regulation of synapse organization is a central biological process that integrates cell adhesion, intracellular scaffolding, post-translational modifications, and glial/neuroimmune signals to shape synaptic structure. Its dysregulation contributes to neurodevelopmental, psychiatric, and neurodegenerative disorders, making it a high-priority area for mechanistic and translational research. Advances in CRISPR-based models and imaging technologies now allow precise interrogation of the genes and pathways that control synapse organization, offering new opportunities for therapeutic discovery.
References
- 1. Duhart JC et al.. 2022. Genetic regulation of central synapse formation and organization in Drosophila melanogaster.. Genetics 221(3) PMID: 35652253
- 2. Chato-Astrain I et al.. 2024. Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation.. Cells 13(5) PMID: 38474384
- 3. Babaev O et al.. 2018. Inhibition in the amygdala anxiety circuitry.. Exp Mol Med 50(4):1-16 PMID: 29628509
- 4. van Oostrum M et al.. 2025. Understanding the molecular diversity of synapses.. Nat Rev Neurosci 26(2):65-81 PMID: 39638892
- 5. Liss A et al.. 2025. Neuroimmune regulation of the prefrontal cortex tetrapartite synapse.. Neuropharmacology 269:110335 PMID: 39904409
- 6. Ribic A et al.. 2019. Emerging Roles of Synapse Organizers in the Regulation of Critical Periods.. Neural Plast 2019:1538137 PMID: 31565044
- 7. Koumoundourou A et al.. 2024. Regulation of hippocampal mossy fiber-CA3 synapse function by a Bcl11b/C1ql2/Nrxn3(25b+) pathway.. Elife 12 PMID: 38358390
- 8. Choi YJ et al.. 2026. Roles of Glia in Synapse Nano-organization.. Adv Neurobiol 48:331-353 PMID: 41569490
